Stavros Taraviras retweeted
Check out this article: A new study by a Greek research group gives hope for the treatment of hydrocephalus - generegther.gr/en/informatio…
Stavros Taraviras retweeted
Nature research paper: Transcription–replication conflicts underlie sensitivity to PARP inhibitors go.nature.com/4amA5dr
Stavros Taraviras retweeted
Fiona Watt has been appointed as next Director of EMBO. Read the press release:
bit.ly/2UKsbsY
Stavros Taraviras retweeted
Learn about Dr. Stavros Taraviras, one of four scientists who received a Hydrocephalus Association 2020 Innovator Award. Dr. Taraviras is working to turn scar tissue back into ependymal cells as a novel therapeutic strategy for treating #hydrocephalus. hydroassoc.org/2020-innovato…
Stavros Taraviras retweeted
I am super excited to share our latest work, out now in @NAR Genomics and Bioinformatics!
1. open-access paper: doi.org/10.1093/nargab/lqaa1…
2. open-sourced code and data: github.com/rapsoman/DNA_Rere…
Buckle up for a Tweetorial 👇
Stavros Taraviras retweeted
ICYMI: NEJM paper on #CRISPR gene editing for sickle cell disease nejm.org/doi/full/10.1056/NE… Anyone know why has this indirect approach (inhibiting an inhibitor of fetal hemoglobin) has advanced more than direct approach of correcting the globin gene mutation in HSC? #sicklecell
Stavros Taraviras retweeted
Institute of Biomolecular Chemistry, National Research Council of Italy invites oncologists and basic scientists with interest in cancer research for hands-on visiting certified traineeship/fellowship. you can refer your students/colleagues/fellows. Apply@ bit.ly/2JsGLA7
Stavros Taraviras retweeted
Very excited to see #easyFRAP-web out @NAR_Open! A web-based tool for the analysis of Fluorescence Recovery After Photobleaching data. Congrats to @marianna_raps @stemcellslab and the rest of the amazing team @upatras Read the paper: goo.gl/Myscyn #FRAP #Bioinformatics – at Glasgow, Scotland
Stavros Taraviras retweeted
''1 in 3 #dementia cases could be prevented if brain health is improved throughout life by targeting 9 risk factors, including continuing education in early life and reducing smoking in later life'' On @alzheimerssoc #DAW2018, read full free commission: hubs.ly/H0c9r1C0
Stavros Taraviras retweeted
Multiple sclerosis — about 2·3 million people are estimated to live with #multiplesclerosis, with global distribution generally increasing with increasing distance from the equator
Learn more in new Seminar on #MS: hubs.ly/H0bqlxC0
Stavros Taraviras retweeted
A new generation of treatments are using the body’s own defense system to fight back cancer.
Learn more in our latest's issue's special feature on cancer immunotherapy: scim.ag/2GgkkdG
Stavros Taraviras retweeted
Perspective: Monoclonal Antibodies for Emerging Infectious Diseases — Borrowing from History nej.md/2toglXb
Stavros Taraviras retweeted
Physicists have created a maser that works in regular conditions — using diamond: go.nature.com/2IP9fPk
Stavros Taraviras retweeted
In this week’s Perspective Audio Interview, Gayatri Devi, MD, discusses assessment and support for physicians with Alzheimer’s disease.
Stavros Taraviras retweeted
Every year EMBL admits an average of 60 new #phd students from around the world. Could you be one of them? The application process for 2018 summer recruitment is now open bit.ly/2FKW9jM
Stavros Taraviras retweeted
Replying to @CellStemCell
@CellStemCell Vascular #tissue #engineering: progress, challenges & clinical promise by Song, Rumma, Edelman @MIT, Chen @BU_Tweets & Ozaki @harvardmed bit.ly/2GlUpPl
Stavros Taraviras retweeted
Gene editing toolbox expands as two research groups announce techniques to make targeted alterations to DNA and RNA: go.nature.com/2yLRXQM
Stavros Taraviras retweeted
3D brain map allows researchers to trace paths of single neurons in mice: go.nature.com/2yRJjO8
Stavros Taraviras retweeted
A big #CRISPR DNA and RNA genome editing day @nature & @sciencemagazine nature.com/polopoly_fs/1.228… summed up well by @ElieDolgin @NatureNews
Stavros Taraviras retweeted
A new class of ‘base editors’ make it possible to individually replace all 4 DNA bases selectively and efficiently go.nature.com/2ixuSL8




























